Advertisement.

BLPH Projected Dividend Yield

Bellerophon Therapeutics Inc ( OTCBB : BLPH )

Bellerophon Therapeutics is a therapeutics company focused on developing products that address medical needs in the treatment of cardiopulmonary diseases. Co.'s focus is the continued development of its nitric oxide therapy for patients with or at risk of pulmonary hypertension (PH) using its proprietary pulsatile nitric oxide delivery platform, INOpulse. Co.'s INOpulse program is an extension of the technology used in hospitals to deliver continuous-flow inhaled nitric oxide. Co. is developing its INOpulse program for the treatment of three additional indications: chronic thromboembolic PH, PH associated with sarcoidosis and PH associated with pulmonary edema from high altitude sickness.

10 YEAR PERFORMANCE RESULTS

BLPH Dividend History Detail
BLPH Dividend News
BLPH Competitors News

# of Shares: 0

Closing Price: 0.02

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
2026	0.00	0%	0	$ 0.00	0.00%
2027	0.00	0%	0	$ 0.00	0.00%
2028	0.00	0%	0	$ 0.00	0.00%
2029	0.00	0%	0	$ 0.00	0.00%
2030	0.00	0%	0	$ 0.00	0.00%
2031	0.00	0%	0	$ 0.00	0.00%
2032	0.00	0%	0	$ 0.00	0.00%
2033	0.00	0%	0	$ 0.00	0.00%
2034	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2024	N/A	Dec 19, 2024	Dec 11, 2024	Dec 18, 2024	0.0190
2024 Total:					0.0190